H100™ is a topical treatment specifically designed to address Peyronie’s disease (PD) in its early stages, known as the acute phase. This is the period when the disease is actively developing, and intervention can be crucial in altering its course. Peyronie’s disease is characterized by the formation of scar tissue (plaque) beneath the skin of the penis.
H100™ is a Peyronie’s disease (PD) treatment that could help men suffering from Acute phase/stage disease when PD is developing. Peyronie’s disease involves a cascade of events in which trauma leads to inflammation, which leads to scar tissue development. Changing the natural course of this cascade was the focus of our research.
Get our newsletter and stay updated on the latest nootropics news, smart drug tips, and exclusive offers delivered straight to your inbox!
Sign up for our newsletter to get up-to-date information, news & insights.
